Ambeed.cn

首页 / 抑制剂/激动剂 / G蛋白偶联受体/G蛋白 / LPA Receptor / Ki16425

Ki16425 {[allProObj[0].p_purity_real_show]}

货号:A114375 同义名: Debio 0719

Ki16425 is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3 with Ki of 0.34 μM, 6.5 μM and 0.93 μM, respectively, shows no activity at LPA4, LPA5, LPA6.

Ki16425 化学结构 CAS号:355025-24-0
Ki16425 化学结构
CAS号:355025-24-0
Ki16425 3D分子结构
CAS号:355025-24-0
Ki16425 化学结构 CAS号:355025-24-0
Ki16425 3D分子结构 CAS号:355025-24-0
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Ki16425 纯度/质量文件 产品仅供科研

货号:A114375 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell Host Microbe, 2024. Ambeed. [ A163338 ]
Cancer Res., 2024. Ambeed. [ A295334 ]
J. Pharm. Investig., 2024. Ambeed. [ A221527 , A691302 , A272538 , A187261 ]
J. Fungi, 2024, 10(11): 751. Ambeed. [ A796919 ]
JBC, 2024, 107935. Ambeed. [ A194396 ]
更多 >
产品名称 LPA1 LPA2 LPA3 其他靶点 纯度
Ki16198 +++

LPA1, Ki: 0.34 μM

++

LPA3, Ki: 0.93 μM

99%+
ONO-7300243 ++++

LPA1, IC50: 0.16 μM

98%
Ki16425 +++

LPA1, Ki: 0.34 μM

+

LPA2, Ki: 6.5 μM

++

LPA3, Ki: 0.93 μM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Ki16425 生物活性

靶点
  • LPA2

    LPA2, Ki:6.5 μM

  • LPA1

    LPA1, Ki:0.34 μM

  • LPA3

    LPA3, Ki:0.93 μM

描述 LPA (lysophosphatidic acid), which has been shown to be involved in certain diseases such as atherosclerosis and cancer, can act through its receptor like LPA receptor 1, LPA receptor 2, or LPA receptor 3 and elicit different biological actions, like Ca2+ mobilization, changing in cAMP accumulation, changing cell shape and motility, and cell proliferation. Ki16425 is a LPA receptor antagonist with Ki values of 0.34μM for mouse LPA receptor 1 and 0.93μM for human LPA receptor 3, but with much higher Ki value for human LPA receptor 2 (Ki=6.5μM). Pre-treatment with 1μM Ki16425 can inhibit LPA-induced [Ca22+]i increase in THP-1 cells and 3T3 fibroblasts. Also, Ki16425 could decrease the This LPA-induced response of inositol phosphate production in 3T3 fibroblasts and A431 cells, but not S1P3- or S1P2-expressing CHO cells, at concentration of 10μM. The cAMP accumulation inhibited by LPA in FRTL-5 thyroid cells in a PTX-sensitive manner could be almost completely suppressed by 10μM Ki16425. Cell proliferation and migration induced by LPA in Swiss 3T3 fibroblasts could be inhibited dose-dependently by Ki16425. Treatment with Ki16425 at dose of 10mg/kg intradermally could improve dermal and lung fibrosis in a mouse model of bleomycin-induced murine scleroderma. Pre-treatment with 10μM for 30 minutes could completely block LPA-induced YAP/TAZ phosphorylation and inhibit Hippo signaling pathway in HEK293A cells.
作用机制 Ki16425 can antagonize the binding of LPA to the receptor, thus competitively inhibiting LPA-induced GTP binding and LPA receptor binding to membrane fractions.[1]

Ki16425 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
CHOK1 cells Function assay Antagonist activity at human recombinant LPA1 receptor expressed in CHOK1 cells assessed as inhibition of lysophosphatidic acid-induced intracellular calcium influx, IC50=0.51 μM 17467986
HEK293 cells Function assay 5 mins Antagonist activity at human LPA1 receptor expressed in HEK293 cells assessed as inhibition of LPA-induced AP-TGF-alpha release treated 5 mins before LPA addition measured after 60 mins 22658556
human chem1 cells Function assay Antagonist activity at LPA1 expressed in human chem1 cells assessed as effect on intracellular calcium mobilization by FLIPR assay, IC50=0.046 μM 20056548
PC-3 cells Function assay Binding affinity for Lysophosphatidic acid receptor in PC-3 cells, Ki=1.74 μM 16033271

Ki16425 动物研究

Dose Mice: 1 mg/kg, 10 mg/kg[2] (i.d.); 20 mg/kg[4] (i.p.); 5 mg/kg[5] (i.v.); 25 mg/kg, 50 mg/kg[5] (p.o.)
Administration i.d., i.p., i.v., p.o.
Pharmacokinetics
Animal Mice[5]
Dose 5 mg/kg (i.v.)
50 mg/kg (p.o.)
Administration i.v.
p.o.
F 14.41% (p.o.)
T1/2 0.49 h (i.v.)
0.98 h (p.o.)
Tmax 0.08 h (i.v.)
0.25 h (p.o.)
CL 6.66 l/h/kg (i.v.)
Cmax 2960 μg/ml (i.v.)
1658 μg/ml (p.o.)

Ki16425 参考文献

[1]Ohta H, Sato K, et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol. 2003 Oct;64(4):994-1005.

[2]Ohashi T, Yamamoto T, et al. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin. Exp Dermatol. 2015 Sep;24(9):698-702.

[3]Yu FX, Zhao B, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012 Aug 17;150(4):780-91.

[4]Sánchez-Marín L, Ladrón de Guevara-Miranda D, et al. Systemic blockade of LPA1/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior. Neuropharmacology. 2018 May 1;133:189-201.

[5]David M, Ribeiro J, et al. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis. Int J Oncol. 2012 Apr;40(4):1133-41.

Ki16425 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.53mL

2.11mL

1.05mL

21.05mL

4.21mL

2.11mL

Ki16425 技术信息

CAS号355025-24-0
分子式C23H23ClN2O5S
分子量 474.957
别名 Debio 0719
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Store in freezer, under -20°C

溶解度

DMSO: 105 mg/mL(221.07 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。